Posted On: 12/08/2014 9:57:20 AM
Post# of 30035
AMBS is trying to position itself so that at the JP Morgan Conference in January, it will be the Belle of the Ball:
LymPro Launch,
MANF/RP Orphan,
MANF/Wolfram's/Eye Data,
Eltoprazine 2b Clinical Trial,
ESS Orphan
Phenoguard's "Plethora" of other discoveries.
I THINK INSTITUTIONS WILL SEE A BUYING OPPORTUNITY once AMBS up lists in late January or early February. Dr. Rubenfeld may replace Gerald as our go to guy SPOKESMAN because of his credibility.
LymPro Launch,
MANF/RP Orphan,
MANF/Wolfram's/Eye Data,
Eltoprazine 2b Clinical Trial,
ESS Orphan
Phenoguard's "Plethora" of other discoveries.
I THINK INSTITUTIONS WILL SEE A BUYING OPPORTUNITY once AMBS up lists in late January or early February. Dr. Rubenfeld may replace Gerald as our go to guy SPOKESMAN because of his credibility.
(0)
(0)Scroll down for more posts ▼
